ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements with these filters
Kronox Lab Sciences Limited held its 17th Annual General Meeting on September 16, 2026. The meeting covered business including final dividend declaration and auditor remuneration ratification.
Kronox Lab Sciences has received the Draft Letter of Offer for an open offer from Indo Borax and Chemicals Limited. The offer covers 95.7 lakh shares.
Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited have filed a Draft Letter of Offer for their open offer to acquire Kronox Lab Sciences shares.
Indo Borax and Chemicals Limited has published a Detailed Public Statement for its open offer to acquire shares of Kronox Lab Sciences Limited.
Indo Borax and Chemicals Limited has launched an Open Offer for Kronox Lab Sciences Limited, valued at ₹105.53 Crore. This mandatory offer follows SEBI regulations.
Kronox Lab Sciences has fixed September 9, 2026, as the record date for determining shareholder eligibility for the previously recommended final dividend of Rs. 0.50 per share.
Kronox Lab Sciences Limited will hold its 17th Annual General Meeting on September 16, 2026, via video conferencing to transact ordinary and special business items.
Kronox Lab Sciences Limited has filed its Annual Report for the financial year 2025-26, along with the notice for its upcoming 17th Annual General Meeting.
Indo Borax and Chemicals, with PAC, announced a mandatory open offer for 25.79% of Kronox Lab Sciences at ₹157.27 per share. This open offer totals ₹150.51 Crore.
Indo Borax and Chemicals will acquire a 64.26% stake in Kronox Lab Sciences for ₹246.12 Crore. The deal triggers a mandatory open offer for an additional 25.79% stake.
Promoters of Kronox Lab Sciences Ltd have executed a Share Purchase Agreement to sell a 64.26% stake to Indo Borax & Chemicals Limited. The transaction triggers a mandatory open offer.
Promoters of Kronox Lab Sciences Ltd have executed a Share Purchase Agreement to sell a 64.26% stake to Indo Borax & Chemicals Limited for ₹246.12 Crore.
Kronox Lab Sciences Limited has issued a notice for its 17th Annual General Meeting to be held on September 16, 2026. The meeting will address financial statements, director re-appointment, and dividend declaration.
Kronox Lab Sciences Ltd reported revenue from operations of ₹28.4 Cr (+16.9% YoY) and net profit of ₹7.3 Cr (+15.9% YoY) for Q1 FY27.
Kronox Lab Sciences Limited will hold a board meeting on August 12, 2026. The board will consider and approve standalone financial results for the June quarter.
Kronox Lab Sciences clarified that recent share volume increases are market-driven. The company confirmed compliance with all material disclosure requirements under SEBI regulations.
Kronox Lab Sciences recommended a final dividend of ₹0.5 per share for FY 2025-26. Record and meeting dates will be finalized in a future meeting.
Kronox Lab Sciences reported annual revenue of ₹101.22 Crore and recommended a ₹0.50 per share final dividend. Results show stable performance for fiscal year 2026.
Kronox Lab Sciences Ltd reported revenue from operations of ₹26.1 Cr (+0.0% YoY) and net profit of ₹8 Cr (+27.0% YoY) for Q4 FY26.
Kronox Lab Sciences reported a total annual income of ₹106.41 Crore and recommended a 5% dividend. The firm maintains consistent profitability for shareholders.
Kronox Lab Sciences scheduled a board meeting on May 21, 2026. Directors will consider FY26 audited financial results and potential dividend recommendations for shareholders.
Kronox Lab Sciences rescheduled its board meeting to May 21, 2026. The board will consider audited annual financial results and a final dividend recommendation.
Kronox Lab Sciences Ltd clarified that recent share price movements are purely market-driven. The company confirmed it has disclosed all material information under SEBI regulations and is unaware of any specific reason for the price fluctuation.
Kronox Lab Sciences Ltd reported net profit of ₹6.6 Cr (+1.5% YoY) for Q3 FY26.
Kronox Lab Sciences Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The filing, received from Kfin Technologies Limited, confirms compliance regarding the dematerialization of securities. This is a routine regulatory disclosure with no immediate material financial impact.